Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mdw328PMID 22997456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic review of oncological outcomes following surgical management of localised renal cancer.

  2012cited by this paper
• Long-term outcomes of renal tumor radio frequency ablation stratified by tumor diameter: size matters.

  2012cited by this paper
• Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.

  2011cited by this paper
• Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.

  2011cited by this paper
• Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

  2011cited by this paper
• Current pathology keys of renal cell carcinoma.

  2011cited by this paper
• Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial

  2010cited by this paper
• Renal cell carcinoma

  2009cited by this paper
• Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

  2009cited by this paper
• Everolimus: in advanced renal cell carcinoma.

  2009cited by this paper
• Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

  2008cited by this paper
• Clinical Progress in Renal Cancer

  2008cited by this paper
• Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.

  2008cited by this paper
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

  2007cited by this paper
• Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

  2007cited by this paper
• Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.

  2007cited by this paper
• Sorafenib in advanced clear-cell renal-cell carcinoma.

  2007cited by this paper
• Radiotherapy and supportive care

  2007cited by this paper
• Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.

  2006cited by this paper
• Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

  2005cited by this paper
• Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.

  2004cited by this paper
• Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay

  2003cited by this paper
• Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma

  2003cited by this paper
• Zoledronic acid delays the onset of skeletal‐related events and progression of skeletal disease in patients with advanced renal cell carcinoma

  2003cited by this paper
• Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.

  1997cited by this paper
• Renal cell carcinoma.

  1956cited by this paper

• Nuclear Imaging in Renal Cell Carcinoma: Current Evidence and Clinical Applications

  2026cites this paper
• A DNN‐Based Weighted Partial Likelihood for Partially Linear Subdistribution Hazard Model

  2026cites this paper
• Construction and validation of renal cell carcinoma tumor cell differentiation-related prognostic classification (RCC-TCDC): an integrated bioinformatic analysis and clinical study

  2025cites this paper
• A systematic review of tumour position reproducibility and stability in breath-hold for radiation therapy of the upper abdomen

  2025cites this paper
• Gastric metastasis of renal cell carcinoma: features, mechanisms, and insights from existing literature

  2025cites this paper
• Disclosing the development and focus of sequencing and omics studies in kidney neoplasm research

  2025cites this paper
• Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1’s role in promoting vasculogenic mimicry in clear cell renal cell carcinoma

  2025cites this paper
• The Diagnostic Performance of Magnetic Resonance Texture Analysis in Histological Subtyping and Grading of the Renal Cell Carcinoma

  2025cites this paper
• Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma

  2025cites this paper
• hsa-miR-21-5p can serve as a standard biomarker in clear cell renal cell carcinoma by promoting tumor progression and influencing immune evasion

  2025cites this paper
• Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art

  2025cites this paper
• GAMT facilitates tumor progression via inhibiting p53 in clear cell renal cell carcinoma

  2025cites this paper
• An interpretable contrast-enhanced CT radiomics–based pipeline incorporating automatic segmentation for predicting ISUP grade group in ccRCC

  2025cites this paper
• The place of stereotactic radiotherapy in the treatment of renal cancer

  2025cites this paper
• The Value of Intratumoral and Peritumoral Radiomics Based on Contrast‐Enhanced Ultrasound for Predicting WHO/ISUP Grading of Clear Cell Renal Cell Carcinoma

  2025cites this paper
• Case Report: Papillary renal cell carcinoma complicated by ipsilateral renal tuberculosis

  2025cites this paper
• Adjuvant Therapy in Renal Cell Cancer

  2024cites this paper
• Serum and Urine Metabolic Fingerprints Characterize Renal Cell Carcinoma for Classification, Early Diagnosis, and Prognosis

  2024cites this paper
• Circ-IP6K2 suppresses tumor progression by modulating the miR-1292-5p/CAMK2N1 signal in clear cell renal cell carcinoma

  2024cites this paper
• Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review

  2024cites this paper
• Predictive quantitative multidetector computed tomography models for characterization of renal cell carcinoma subtypes and differentiation from renal oncocytoma: nomogram algorithmic approach analysis

  2024cites this paper
• Health Care Resource Use for Modern First-Line Treatments in Metastatic Renal Cell Carcinoma

  2024cites this paper
• Nivolumab in patients with advanced renal cell carcinoma in France: interim results of the observational, real-world WITNESS study

  2024cites this paper
• Predictive factors of nivolumab plus ipilimumab treatment efficacy in metastatic renal cell carcinoma patients

  2024cites this paper
• Prevalence of Postoperative Morbidity in Patients Undergoing Elective Open Major Thoracoabdominal Oncosurgery and Their Correlation with Perioperative Management

  2024cites this paper
• Qualitative and quantitative assessment of non-clear cell renal cell carcinoma using contrast-enhanced ultrasound

  2024cites this paper
• Perioperative, functional, and oncological outcomes after cryoablation or partial nephrectomy for small renal masses in solitary kidneys: a systematic review and meta-analysis

  2024cites this paper
• Long-term outcomes after surgical resection of pancreatic metastases from renal Clear-cell carcinoma.

  2024cites this paper
• Identification of tumor-antigen signatures and immune subtypes for messenger RNA vaccine selection in advanced clear cell renal cell carcinoma.

  2024cites this paper
• Stereotactic Body Therapy for Urologic Cancers—What the Urologist Needs to Know

  2024cites this paper
• Ultrasound contrast-enhanced radiomics model for preoperative prediction of the tumor grade of clear cell renal cell carcinoma: an exploratory study

  2024cites this paper
• Efficacy and toxicity of immune checkpoint inhibitors combination therapy for advanced renal cell carcinoma: a systematic review and network meta-analysis

  2024cites this paper
• Machine learning-based multiparametric MRI radiomics nomogram for predicting WHO/ISUP nuclear grading of clear cell renal cell carcinoma

  2024cites this paper
• Own experience of using combination therapy in the first line of treatment of metastatic renal cell carcinoma

  2024cites this paper
• CCDC25 suppresses clear cell renal cell carcinoma progression by LATS1/YAP-mediated regulation of the hippo pathway

  2024cites this paper
• A fatal case of cabozantinib-induced cardiomyopathy.

  2024cites this paper
• US-guided ablation of tumors – where is it used and how did we get there

  2023cites this paper
• Metastasis of incidentally diagnosed renal cell carcinoma to the sacrum 7 years after partial nephrectomy: Case report and literature review

  2023cites this paper
• RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability

  2023cites this paper
• Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma

  2023cites this paper
• Stereotactic ablative radiotherapy for primary renal cell carcinoma

  2023cites this paper
• Skeletale Oligometastasierung bei Brust- und Nierenzellkarzinomen

  2023cites this paper
• PAK5 potentiates slug transactivation of N-cadherin to facilitate metastasis of renal cell carcinoma.

  2023cites this paper
• Serum Oxidative and Nitrosative Stress Markers in Clear Cell Renal Cell Carcinoma

  2023cites this paper
• Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study.

  2023cites this paper
• Intraoperative MRI-derived volumetric ablation margins and initial correlation with local outcome after MRI-guided cryoablation of renal tumors

  2023cites this paper
• Comparison of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma with rhabdoid and sarcomatoid differentiations

  2023cites this paper
• Research in interventional oncology: How sound is the evidence base?

  2023cites this paper
• Perioperative, functional, and oncologic outcomes after ablation or partial nephrectomy for solitary renal tumors: a systematic review and meta-analysis of comparative trials

  2023cites this paper
• N6‐methyladenosine‐modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2/YAP axis‐regulated Hippo pathway

  2023cites this paper
• Adjuvant Therapy for High-Risk Localized Renal Cell Carcinoma: Current Landscape and Future Direction

  2023cites this paper
• Overexpression of complement C5a indicates poor survival and therapeutic response in metastatic renal cell carcinoma

  2023cites this paper
• Research Progress on Circulating Tumor DNA in Renal Cell Carcinoma

  2023cites this paper
• Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy

  2023cites this paper
• Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study

  2023cites this paper
• Metastatic Renal Cell Carcinoma to the Soft Tissue 27 Years after Radical Nephrectomy: A Case Report

  2023cites this paper
• Cardiotoxicity of Selected Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Renal Cell Carcinoma

  2023cites this paper
• Investigation of Underlying Biological Association and Targets between Rejection of Renal Transplant and Renal Cancer

  2023cites this paper
• A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma

  2023cites this paper
• Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease Model.

  2023cites this paper
• Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics

  2023cites this paper
• Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival

  2022cites this paper
• Prognostic value of the ratio of maximum to minimum diameter of primary tumor in metastatic clear cell renal cell carcinoma

  2022cites this paper
• Spindle pole body component 24 homolog potentiates tumor progression via regulation of SRY‐box transcription factor 2 in clear cell renal cell carcinoma

  2022cites this paper
• Utilisation of virtual non-contrast images and virtual mono-energetic images acquired from dual-layer spectral CT for renal cell carcinoma: image quality and radiation dose

  2022cites this paper
• Comparative study of conventional diffusion-weighted imaging and introvoxel incoherent motion in assessment of pathological grade of clear cell renal cell carcinoma.

  2022cites this paper
• Therapeutic Options in Metastatic Renal Cancer

  2022cites this paper
• A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma

  2022cites this paper
• Management and Health Resource Use of Patients With Metastatic Renal Cell Carcinoma treated With Systemic Therapy Over 2014-2017 in France: A National Real-World Study.

  2022cites this paper
• The Non-Interventional PAZOREAL Study to Assess the Effectiveness and Safety of Pazopanib in a Real-Life Setting: Reflecting a Changing mRCC Treatment Landscape

  2022cites this paper
• An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives

  2022cites this paper
• Clinical Effect of Retroperitoneal Laparoscopic Radical Nephrectomy on Renal Cell Carcinoma, the Influence of Renal Function, and the Influencing Factors of Recurrence

  2022cites this paper
• The role of thermoablative methods in the treatment of renal tumors

  2022cites this paper
• Impact of Time-To-Surgery on the Prognosis of Patients with T1 Renal Cell Carcinoma: Implications for the COVID-19 Pandemic

  2022cites this paper
• Long Noncoding RNA MMP2-AS1 Contributes to Progression of Renal Cell Carcinoma by Modulating miR-34c-5p/MMP2 Axis

  2022cites this paper
• Clinicopathological features of non-conventional renal cell carcinoma histological subtypes: Learning points from a large contemporary series spanning over three decades

  2022cites this paper
• Efficacy and Safety of Nivolumab for Advanced Renal Cell Carcinoma: A Systematic Review and Meta-Analysis

  2022cites this paper
• Identifying Valid Algorithms for Number of Lines of Anti-Neoplastic Therapy in the Danish National Patient Registry Among Patients with Advanced Ovarian, Gastric, Renal Cell, Urothelial, and Non-Small Cell Lung Cancer Attending a Danish University Hospital

  2022cites this paper
• Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Through CT-Based Tumoral and Peritumoral Radiomics

  2022cites this paper
• Long non-coding RNA CYTOR modulates cancer progression through miR-136-5p/MAT2B axis in renal cell carcinoma.

  2022cites this paper
• Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy

  2021cites this paper
• The Role of Kinase Inhibitors in Cancer Therapies

  2021cites this paper
• How We Do It: Managing the Indeterminate Renal Mass with the MRI Clear Cell Likelihood Score.

  2021cites this paper
• Deep Learning-Based Magnetic Resonance Imaging in the Evaluation of Tumor, Node, and Metastasis Staging of Renal Cancer

  2021cites this paper
• Gut Microbiota and Sunitinib-Induced Diarrhea in Metastatic Renal Cell Carcinoma: A Pilot Study

  2021influential citation
• Renal Cancer

  2021cites this paper
• Targeting Carbonic Anhydrase IX in Tumor Imaging and Theranostic Cancer Therapy

  2021cites this paper
• Intractable Cough Associated With Renal Cell Carcinoma

  2021influential citation
• The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth

  2021cites this paper
• AGO2 expression levels and related genetic polymorphisms: influence in renal cell progression and aggressive phenotypes.

  2021cites this paper
• Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling.

  2021cites this paper
• The Association of Controlling Nutritional Status (CONUT) Score with Survival in Patients with Surgically Treated Renal Cell Carcinoma and Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis

  2021cites this paper
• Polyethylene glycol-coated collagen patch (hemopatch®) in open partial nephrectomy

  2021cites this paper
• Expression of the CXCR4 and CXCR7 in renal cancers; can "the orphan receptor" predict the mortality?

  2021cites this paper
• Traditional Chinese medicine Bu-Shen-Jian-Pi-Fang attenuates glycolysis and immune escape in clear cell renal cell carcinoma: results based on network pharmacology

  2021cites this paper
• CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma

  2021cites this paper
• Treatment and Survival in Advanced Non-Small Cell Lung Cancer, Urothelial, Ovarian, Gastric and Kidney Cancer: A Nationwide Comprehensive Evaluation

  2021cites this paper
• Learnable image histograms-based deep radiomics for renal cell carcinoma grading and staging

  2021influential citation
• The compound AST-003 could effectively promote apoptosis of renal cell carcinoma cells in vitro

  2021cites this paper
• Radiotherapy and Renal Cell Carcinoma: A Continuing Saga

  2021cites this paper